Trump Administration Negotiates Lower Costs for Weight Loss Drugs

Discounted GLP-1 Medications

• 🎯 President Trump announced a new pharmaceutical agreement to lower the cost of GLP-1 injectables for weight loss.
• 💰 Eligible Medicare and Medicaid patients will be able to receive these injectables for $245 per month.
• 💊 Oral GLP-1 medications will also be available under similar criteria for $149 per month.
• 📈 An estimated 10% of Medicare beneficiaries are expected to qualify for this expanded access.

Medicare Coverage and New Developments

• ⚠️ Medicare is legally prohibited from covering weight loss medications, but can cover GLP-1s for heart conditions; the method for circumventing this rule is unclear.
• 🔬 Eli Lilly is advancing to late-stage trials for a new obesity drug designed to aid weight loss while preserving muscle mass by slowing digestion and suppressing hunger.